Using yoga to help relieve pain from chemotherapy-induced nerve damage
Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial
This study is looking at whether an eight-week yoga program can help ease the pain and improve the quality of life for cancer survivors dealing with nerve pain from chemotherapy, and it’s open to people who want to try a natural way to feel better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11047709 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of yoga as a treatment for chemotherapy-induced peripheral neuropathy (CIPN), a painful condition affecting many cancer survivors. The study will involve a phase III trial with 268 participants, comparing the effects of an eight-week yoga program against usual care and an education control group. Participants will be assessed for improvements in pain, flexibility, quality of life, and the risk of falls. The goal is to provide a non-pharmacological approach to alleviate the debilitating symptoms associated with CIPN.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer survivors experiencing moderate to severe pain from chemotherapy-induced peripheral neuropathy.
Not a fit: Patients who are not experiencing CIPN or those who have severe mobility limitations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide cancer survivors with a safe and effective way to reduce pain and improve their quality of life.
How similar studies have performed: Previous pilot studies have shown promising results for yoga in reducing CIPN pain, suggesting that this approach may be effective.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Bao, Ting — Dana-Farber Cancer Inst
- Study coordinator: Bao, Ting
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.